Dogwood Therapeutics

(NASDAQ) VIRI

Current PriceN/A

Market CapN/A

Since IPO (2020)-100%

5 Year-99%

1 Year-70%

1 Month+24%

Dogwood Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$12.14B

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

VIRI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Dogwood Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Gregory Duncan, MBA

Website

www.dwtx.com

Headquarters

Alpharetta, GA 30009, US

VIRI Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-254%

Return on Assets

128%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$27.97B

EBITDA

-$27.97M

Operating Cash Flow

-$15.62B

Capital Expenditure

$0.00

Free Cash Flow

-$15.62B

Cash & ST Invst.

$6.52M

Total Debt

$0.00

Dogwood Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$4.99M

+100.0%

EBITDA

-$5.08M

+99.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$13.08M

-99.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$87.62K

-99.9%

Short Term Debt

$57.31K

-99.9%

Return on Assets

127.52%

N/A

Return on Invested Capital

-254.12%

N/A

Free Cash Flow

-$4.59M

+99.9%

Operating Cash Flow

-$4.59M

+99.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BLPHBellerophon Therapeutics, Inc.

BLPHBellerophon Therapeutics, Inc.$0.01-36.84%

TFFPTFF Pharmaceuticals, Inc.

TFFPTFF Pharmaceuticals, Inc.$0.07-60.05%

KERNAkerna Corp.

KERNAkerna Corp.$0.31+36.94%

ATLNAtlantic International Corp.

ATLNAtlantic International Corp.$1.50+7.91%

LFLYLeafly Holdings, Inc.

LFLYLeafly Holdings, Inc.$37.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCEVirgin Galactic

SPCEVirgin Galactic$6.18+0.36%

FFord Motor Company

FFord Motor Company$17.44+0.05%

ONDSOndas

ONDSOndas$13.22-0.00%

BBAIBigBear.ai

BBAIBigBear.ai$5.04+0.02%

HPEHewlett Packard Enterprise

HPEHewlett Packard Enterprise$43.04+0.13%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.64-0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.92-0.03%

Questions About VIRI

What is the current price of Dogwood Therapeutics?

Dogwood Therapeutics is trading at N/A per share.

What is the 52-week range for Dogwood Therapeutics?

Over the past 52 weeks, Dogwood Therapeutics has traded between N/A and N/A.

How much debt does Dogwood Therapeutics have?

As of the most recent reporting period, Dogwood Therapeutics reported total debt of $144.93K.

How much cash does Dogwood Therapeutics have on hand?

Dogwood Therapeutics reported $13.23M in cash and cash equivalents in its most recent financial results.

What is Dogwood Therapeutics’s dividend yield?

Dogwood Therapeutics does not currently have a dividend yield.

Dogwood Therapeutics

Dogwood Therapeutics Financials at a Glance

VIRI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Dogwood Therapeutics

VIRI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Dogwood Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VIRI

What is the current price of Dogwood Therapeutics?

What is the 52-week range for Dogwood Therapeutics?

How much debt does Dogwood Therapeutics have?

How much cash does Dogwood Therapeutics have on hand?

What is Dogwood Therapeutics’s dividend yield?

Premium Investing Services